Core Scientific, Inc.

Core Scientific, Inc.

11.94
CHF
- -
- -
-0.23EPS
Mar 30Next Earn

Important Dates

Core Scientific Inc's next confirmed earnings release is scheduled for March 30, 2027.

Earnings Date3/30/2027

Share Statistics

As of September 30, 2026, Core Scientific Inc has 321.97M shares outstanding.

Shares Outstanding321.97M

Financial Position

As of September 30, 2026, Core Scientific Inc maintains a current ratio of 0.67, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -393.94, indicating conservative leverage, while an interest coverage ratio of -76.23 demonstrates limited ability to service its debt obligations.

Current Ratio0.67
Quick Ratio0.52
Debt / Equity-393.94
Debt / EBITDA-11.62
Interest Coverage-76.23

Financial Efficiency

CHF

These figures cover the twelve months ended September 30, 2026. Return on assets (ROA) is negative at -2.68, reflecting losses generated across the asset base. The company generates approximately 1.52M in revenue per employee across its workforce of 325.00, a quick read on workforce productivity versus industry peers.

Return on Assets (ROA)-2.68
Revenue Per Employee1.52M
Employee Count325.00

Taxes

CHF

Over the twelve months ended September 30, 2026, Core Scientific Inc recorded an income tax benefit of -86.69M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -178.64M and -91.95M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax-86.69M

Income Statement

CHF

Over the twelve months ended September 30, 2026, Core Scientific Inc generated 493.96M in revenue and converted that into -91.95M in net income, yielding earnings per share of -0.23. EBITDA reached -308.90M, while operating income came in at -60.23M.

Revenue493.96M
Gross Profit203.71M
Operating Income-60.23M
Pretax Income-178.64M
Net Income-91.95M
EBITDA-308.90M
EBIT-365.00M
Earnings Per Share (EPS)-0.23

Balance Sheet

CHF

As of September 30, 2026, Core Scientific Inc holds 670.72M in cash and equivalents against 3.59B in total debt, resulting in a net debt position of 2.92B. Total book value stands at -911.11M, with working capital of -571.54M providing operational flexibility.

Cash & Cash Equivalents670.72M
Total Debt3.59B
Net Debt2.92B
Equity (Book Value)-911.11M
Book Value Per Share-2.83
Working Capital-571.54M

Cash Flow

CHF

Core Scientific Inc produced 374.86M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -1.48B in capital expenditures, free cash flow totaled -1.10B - equivalent to -3.40 per share.

Operating Cash Flow374.86M
Capital Expenditures-1.48B
Free Cash Flow-1.10B
FCF Per Share-3.40

Margins

Over the twelve months ended September 30, 2026, Core Scientific Inc posted a gross margin of 41.24, reflecting its pricing power and cost economics. The operating margin of -12.19 and net profit margin of -18.62 provide insight into operational efficiency.

Gross Margin41.24
Operating Margin-12.19
Pretax Margin-36.16
Profit Margin-18.62
EBITDA Margin-62.53